tiprankstipranks
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF)
OTHER OTC:SFOSF
Holding SFOSF?
Track your performance easily

Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Financial Statements

22 Followers

Shanghai Fosun Pharmaceutical (Group) Co Financial Overview

Shanghai Fosun Pharmaceutical (Group) Co's market cap is currently ―. The company's EPS TTM is $0.11; its P/E ratio is 16.95; and it has a dividend yield of 2.05%. Shanghai Fosun Pharmaceutical (Group) Co is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue¥ 12.34B-¥ 10.96B¥ 10.38B¥ 11.96B
Gross Profit¥ 6.08B-¥ 5.24B¥ 4.52B¥ 5.11B
EBIT¥ 1.44B-¥ 1.72B¥ 1.09B¥ 1.58B
EBITDA¥ 1.44B-¥ 1.72B¥ 1.09B¥ 1.58B
Net Income Common Stockholders¥ 1.28B-¥ 1.08B¥ 462.51M¥ 1.17B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 17.17B¥ 0.00¥ 14.64B¥ 14.08B¥ 14.55B
Total Assets¥ 107.16B-¥ 98.80B¥ 95.77B¥ 93.29B
Total Debt¥ 30.25B¥ 0.00¥ 29.99B¥ 26.71B¥ 24.25B
Net Debt¥ 13.08B¥ 0.00¥ 15.34B¥ 12.64B¥ 9.70B
Total Liabilities¥ 53.05B-¥ 51.07B¥ 48.01B¥ 44.92B
Stockholders Equity¥ 44.58B¥ 0.00¥ 38.20B¥ 38.33B¥ 39.19B
Cash Flow-
Free Cash Flow¥ -369.02M-¥ -141.53M¥ -633.43M¥ -538.06M
Operating Cash Flow-----
Investing Cash Flow¥ 138.37M-¥ -1.02B¥ -1.47B¥ -1.27B
Financing Cash Flow¥ -514.65M-¥ 876.62M¥ 1.54B¥ -86.59M
Currency in CNY

Shanghai Fosun Pharmaceutical (Group) Co Earnings and Revenue History

Shanghai Fosun Pharmaceutical (Group) Co Debt to Assets

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow

Shanghai Fosun Pharmaceutical (Group) Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis